Abstract:Introduction: Epigenetic markers including 5-metylcytosine (5mC) can reflect disease severity and treatment effect. Stroke is a multifactorial disease causing aberrant DNA methylation (DNAm) and memory damage. Hypothesis: Models built for 5mC biomarker panel signatures may be useful for quantitative prediction of post-stroke long-term memory recovery in response to treatment. Methods: Stroke was induced with a middle cerebral artery occlusion (MCAO)(18 rats: sham(6), stroke(6), and stroke with treatment (6)). Xe-liposomes were intravenously administrated repetitively for 3 days after MCAO. At day 35, memory was assessed and scaled using a novel objective recognition test. Brain hippocampus and cortex tissue samples were prepared for whole-genome bisulfite sequencing (WGBS) to generate quantitative DNA methylation datasets in response to repetitive intermittent Xe administration. The resulting WGBS data were evaluated and quantitatively associated with memory recovery. Results: A post-stroke long-term memory outcome model was generated with scaled data using the following inputs: (1) good recovery, (2) moderate recovery, (3) edge, (4) light damage, and (5) severe damage. Differential DNAm 5mC analysis was performed comparing MCAO affected hemisphere with sham and Xe-treated samples. Initial 5mC differential analysis identified 6,175 (Cortex), and 9,037 (Hippocampus) CpG sites that were different between groups. Subsequently the LASSO algorithm was applied and selected 22 CpG sites that correlated with the long-term memory recovery scale. PCA analysis using the 22 CpGs demonstrated separation of memory outcomes. We have also built a predictive linear regression model of the 22 CpGs to assess memory loss or recovery in response to treatment. Analysis showed 7 out of 22 CpGs are conserved in humans (orthologs) for 30 bp regions. Conclusions: Epigenetic 5mC marker panels have the potential for quantitating post-stroke memory damages/recovery.

Tet Enzymes-Mediated DNA 5hmc Modification in Cerebral Ischemic and Hemorrhagic Injury

Effects of Intracerebral Hemorrhage on 5-Hydroxymethylcytosine Modification in Mouse Brains.

Spatial Distribution of 5-Hydroxymethyl Cytosine in Rat Brain and Temporal Distribution in Striatum

5-Hydroxymethylcytosine: generation, fate, and genomic distribution.

From Development to Diseases: the Role of 5hmc in Brain.

The Role of DNA Methylation in Ischemic Stroke: A Systematic Review

Transcriptome-Wide 5-Methylcytosine Profiling of lncRNAs in the Mouse Cerebral Ischemia Model

Abstract 14166: Epigenetic Biomarkers Correlate with Post-stroke Long-term Memory Recovery

Genomic Distribution and Possible Functions of DNA Hydroxymethylation in the Brain.

The Role of DNA Methylation in Stroke Recovery

The role of m5C methyltransferases in cardiovascular diseases

The Emerging Role of Epigenetics in Cerebral Ischemia

Alteration of N6-methyladenosine Modi Fi Cation Pro Fi Les in the Neutrophilic RNAs Following Ischemic Stroke

5-Hydroxymethylcytosine and Disease.

Connecting the dots: Involvement of methyltransferase-like 3, N6-methyladenosine modification, and ferroptosis in the pathogenesis of intracerebral hemorrhage pathogenesis

Homocysteine restrains hippocampal neurogenesis in focal ischemic rat brain by inhibiting DNA methylation

Role of m6A RNA Methylation in Ischemic Stroke

The Role of RNA m5C Modification in Central Nervous System Diseases

N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential

Role of N6-methyladenosine modification in pathogenesis of ischemic stroke

The relationship of plasma homocysteine levels and polymorphism in homocysteine metabolism related enzymes with brain stroke